Catalent
CTLT
$56.08
Share price
0.05%
Change (1 day)
24.79%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
Operating Margin for Catalent (CTLT)
Operating Margin as of April 2024 (TTM): 4.60%
According to Catalent's latest financial reports and stock price the company's current Operating Margin is 4.60%. At the end of 2022 the company had an Operating Margin of 15.08%.
Operating Margin history for Catalent from 2013 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 15.08% | -26.93% |
| 2021 | 20.64% | 65.21% |
| 2020 | 12.49% | 15.97% |
| 2019 | 10.77% | 0.73% |
| 2018 | 10.69% | -1.68% |
| 2017 | 10.88% | -13.89% |
| 2016 | 12.63% | 6.31% |
| 2015 | 11.88% | -5.8% |
| 2014 | 12.61% | 26.63% |
| 2013 | 9.96% | -16.36% |
| 2012 | 11.91% | 13.92% |
| 2011 | 10.45% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | 9.10% | 97.83% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | -6.99% | -251.96% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | -10.86% | -336.09% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | -59.02% | -1,383.04% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.